What is Kins?
Founded in 2021 under the incubation of Redesign Health, Kins operates as a specialized physical therapy platform designed for active individuals who demand both high-quality clinical outcomes and modern accessibility. The company utilizes a hybrid care framework, allowing patients to engage in personalized treatment plans that seamlessly integrate virtual consultations with traditional in-person therapy sessions. This approach addresses the growing demand for flexible, data-driven rehabilitation services, enabling therapists to maintain continuous oversight of patient progress while reducing the friction typically associated with conventional physical therapy programs. By prioritizing the patient-therapist relationship, Kins is effectively disrupting the traditional outpatient rehabilitation market.
How much funding has Kins raised?
Kins has raised a total of $14.2M across 2 funding rounds:
Angel/Seed
$7.2M
Series A
$7M
Angel/Seed (2022): $7.2M with participation from W Health Ventures and Redesign Health
Series A (2024): $7M led by Healthworx, W Health Ventures, and Redesign Health
Key Investors in Kins
Healthworx
Healthworx is a specialized chiropractic and wellness center focused on individualized pain relief and functional neurology, providing deep clinical expertise to the healthcare ecosystem.
W Health Ventures
W Health Ventures is an investment firm dedicated to building generational healthcare companies, offering operational support and domain expertise to startups in the US and India.
Redesign Health
Redesign Health is a venture studio that ideates, builds, and scales innovative healthcare solutions to address systemic challenges and advance human health outcomes.
What's next for Kins?
With this recent capital injection, Kins is well-positioned to scale its operations and expand its footprint within the competitive healthcare technology space. The company's strategic roadmap likely involves enhancing its proprietary digital platform to further personalize patient care pathways and potentially expanding its network of clinical partners. As the healthcare industry continues to shift toward value-based care models, Kins's ability to demonstrate improved patient outcomes through its hybrid delivery system will be paramount. Investors are clearly betting on the company's capacity to standardize high-quality physical therapy, potentially setting a new benchmark for how musculoskeletal conditions are managed in a post-pandemic, digitally-enabled world.
See full Kins company page
